-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$1.50-93.42% Downside
Rigel Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Rigel Pharmaceuticals, Inc.?
Rigel Pharmaceuticals, Inc. has been rated by research analysts at Piper Sandler, Jefferies in the past 90 days.